|
| |
@alkermes.com Pages on BioPortfolio:
BioPortfolio - Alkermes Incorporated
Alkermes Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/371-Alkermes_Incorp...
|
BioPortfolio - Alkermes Incorporated - Profile
View the current Alkermes Incorporated Page on BioPortfolio.com ... Alkermes, Inc. is applying the tools of biotechnology to the development of ...
http://www.bioportfolio.com/biocorporate/371-Alkermes%252BIn...
|
Alkermes®, Inc
View the current Alkermes®, Inc Page on BioPortfolio.com ... Alkermes®, Inc. is a global leader in the development of novel medicines based on sophisticated ...
http://www.bioportfolio.com/biocorporate/18202-Alkermes%2525...
|
BioPortfolio - Biocorporate Search MA
Alkermes®, Inc. is a global leader in the development of novel medicines ... Alkermes, Inc. is applying the tools of biotechnology to the development of ...
http://www.bioportfolio.com/biocorporate/search/region/MA.ht...
|
BioPortfolio - Biocorporate Search biotechnology
Alkermes, Inc. is applying the tools of biotechnology to the development of ... Alkermes is developing product candidates based on its independent drug. ...
http://www.bioportfolio.com/biocorporate/search.php?q=biotec...
|
BioPortfolio - Biocorporate Search pharmaceutical
Alkermes®, Inc. is a global leader in the development of novel medicines based on sophisticated ... We were founded... www.alkermes.com/ View full profile ...
http://www.bioportfolio.com/biocorporate/search.php?q=pharma...
|
BioPortfolio - BioPortfolio - Alkermes Incorporated
BioPortfolio - Alkermes Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/371/www.alk...
|
Alkermes and Indevus start pulmonary disease study
Alkermes and Indevus Pharmaceuticals have started a phase IIa study of ALKS 27 in patients with chronic obstructive pulmonary disease. ...
http://www.bioportfolio.com/biotech_news/Datamonitor_63.htm...
|
Biotechnology News Alkermes Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
Peptides 2006: New Applications in Discovery, Manufacturing, and ...
Alkermes is focused on the development and commercialisation of therapeutic ... In August 2003, Alkermes offered $100 million aggregate principal amount of ...
http://www.bioportfolio.com/cgi-bin/acatalog/9214_peptides.p...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - Alkermes Incorporated
Alkermes Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/371-Alkermes_Incorp...
|
Alkermes’ Corporate Presentation to be Webcast at JPMorgan...
26 Nov 2008 ... (BUSINESS WIRE)--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by JPMorgan on Friday, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=118889...
|
Cephalon | U.S. Government Organizations Release Positive ...
Alkermes and Cephalon Issue Statement in Response to COMBINE Study Publication; ... Alkermes and Cephalon Receive FDA Approval of Vivitrol(TM) for the ...
http://www.cephalon.com/media/news-releases/product/vivitrol...
|
Alkermes®, Inc
View the current Alkermes®, Inc Page on BioPortfolio.com ... Alkermes®, Inc. is a global leader in the development of novel medicines based on sophisticated ...
http://www.bioportfolio.com/biocorporate/18202-Alkermes%2525...
|
Cephalon | U.S. Government Organizations Release Positive ...
Alkermes and Cephalon Receive FDA Approval of Vivitrol(TM) for the .... VIVITROL was developed and is manufactured by Alkermes and is marketed by Cephalon. ...
http://www.cephalon.com/media/news-releases/by-product/produ...
|
Alkermes’ Corporate Presentation to be Webcast at Two Upcoming ...
The presentations will be webcast from New York City and may be accessed under the investor relations tab at www.alkermes.com. The presentations will be ...
http://www.biospace.com/news_story.aspx?NewsEntityId=108545...
|
BioPortfolio - Alkermes Incorporated - Profile
View the current Alkermes Incorporated Page on BioPortfolio.com ... Alkermes, Inc. is applying the tools of biotechnology to the development of ...
http://www.bioportfolio.com/biocorporate/371-Alkermes+Incorp...
|
ALKS: Profile for Alkermes, Inc. - Yahoo! Finance
See the company profile for Alkermes, Inc. (ALKS) including business summary, industry/sector information, number of employees, business summary, ...
http://biz.yahoo.com/p/A/ALKS.html...
|
FDA Approves New Dose of Janssen, L.P. and Alkermes's RISPERDAL(R ...
Using proprietary Medisorb® drug-delivery technology developed by Alkermes, the RISPERDAL CONSTA formulation encapsulates risperidone in microspheres made ...
http://www.biospace.com/news_story.aspx?NewsEntityId=52147...
|
Alkermes to Host Conference Call to Discuss Financial Results for ...
Alkermes to Host Conference Call to Discuss Financial Results for Second Quarter of Fiscal 2009. - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes ...
http://biz.yahoo.com/bw/081030/20081030005953.html...
|
|
